Data Foundry

Drug recalls 2019

FENTANYL Transdermal System — Class I drug recall D-1277-2019

Terminated recall by Alvogen, Inc, reported 2019-05-15, distributed nationwide. Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contain

Recall numberD-1277-2019
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAlvogen, Inc, Pine Brook, NJ, United States
Recall initiated2019-04-19
Classified2019-05-13
Reported by FDA2019-05-15
Terminated2019-08-14
DistributedNationwide (US)
Quantity119,608 cartons
Reason classeslabeling
NDC47781-0423, 47781-0423-11, 47781-0423-47, 47781-0424, 47781-0424-11, 47781-0424-47, 47781-0426, 47781-0426-11, 47781-0426-47, 47781-0427, 47781-0427-11, 47781-0427-47, 47781-0428, 47781-0428-11, 47781-0428-47
Lot numbers180060, 180073
Expiration dates2020-05, 2020-06

Product

FENTANYL Transdermal System, 12 mcg/h, five (12 mcg/h) systems per carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058; Manufactured by: 3M Drug Delivery Systems, St. Paul, MN 55107, NDC 47781-423-47.

Reason for recall

Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1277-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.